SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-20-020503
Filing Date
2020-12-01
Accepted
2020-12-01 19:55:17
Documents
3
Period of Report
2020-12-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 2473
2 exhibit99-1.htm EX-99.1 2917
3 exhibit99-2.htm EX-99.2 17663
  Complete submission text file 0001567619-20-020503.txt   24309
Mailing Address
Business Address
SHULMAN JOHN D (Reporting) CIK: 0001208886 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39752 | Film No.: 201362124

Mailing Address 5301 WISCONSIN AVENUE NW SUITE 570 WASHINGTON DC 20015
Business Address 5301 WISCONSIN AVENUE NW SUITE 570 WASHINGTON DC 20015 301-215-7440
Petros Pharmaceuticals, Inc. (Issuer) CIK: 0001815903 (see all company filings)

IRS No.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations